{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:28:54Z","timestamp":1790782134768,"version":"4.1.0"},"reference-count":119,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00162","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T23:34:38Z","timestamp":1551224078000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":114,"title":["The Molecular Mechanism of Transforming Growth Factor-\u03b2 Signaling for Intestinal Fibrosis: A Mini-Review"],"prefix":"10.3389","volume":"10","author":[{"given":"Sun-Mi","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-017-0047-4","article-title":"Recent advances in the treatment of skin involvement in systemic sclerosis.","volume":"37","author":"Asano","year":"2017","journal-title":"Inflamm. Regen."},{"key":"B2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1053\/gast.1996.v110.pm8613031","article-title":"Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.","volume":"110","author":"Babyatsky","year":"1996","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/rheumatology\/ken405","article-title":"Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.","volume":"48","author":"Badea","year":"2009","journal-title":"Rheumatology"},{"key":"B4","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1242\/jcs.115.15.3193","article-title":"p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.","volume":"115","author":"Bakin","year":"2002","journal-title":"J. Cell Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1089\/ars.2012.4653","article-title":"A synthetic peptide from transforming growth factor-beta(1) type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats.","volume":"19","author":"Baltanas","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"B6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s00535-002-1101-8","article-title":"Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17.","volume":"38","author":"Bamba","year":"2003","journal-title":"J. Gastroenterol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","article-title":"Growth factors and cytokines in wound healing.","volume":"16","author":"Barrientos","year":"2008","journal-title":"Wound Repair Regen."},{"key":"B8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2353\/ajpath.2007.070056","article-title":"A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II.","volume":"171","author":"Belmadani","year":"2007","journal-title":"Am. J. Pathol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-6-13","article-title":"The role of interleukin 17 in Crohn\u2019s disease-associated intestinal fibrosis.","volume":"6","author":"Biancheri","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1053\/j.gastro.2006.09.016","article-title":"Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.","volume":"131","author":"Boirivant","year":"2006","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/ibd.21543","article-title":"N-cadherin is overexpressed in Crohn\u2019s stricture fibroblasts and promotes intestinal fibroblast migration.","volume":"17","author":"Burke","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.crohns.2012.02.009","article-title":"Treatment of inflammatory bowel diseases: to heal the wound or to heal the sick?","volume":"6","author":"Caprilli","year":"2012","journal-title":"J. Crohns Colitis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.etp.2008.04.010","article-title":"A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice.","volume":"61","author":"Chen","year":"2009","journal-title":"Exp. Toxicol. Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1172\/JCI119815","article-title":"Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.","volume":"100","author":"Clouthier","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases.","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/gut.2004.045294","article-title":"Impact of the increasing use of immunosuppressants in Crohn\u2019s disease on the need for intestinal surgery.","volume":"54","author":"Cosnes","year":"2005","journal-title":"Gut"},{"key":"B17","first-page":"134","article-title":"Myofibroblast differentiation during fibrosis.","volume":"3","author":"Desmouliere","year":"1995","journal-title":"Exp. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s10067-004-0906-7","article-title":"Experience with azathioprine in systemic sclerosis associated with interstitial lung disease.","volume":"23","author":"Dheda","year":"2004","journal-title":"Clin. Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171093","article-title":"Role of glycogen synthase kinase-3beta and PPAR-gamma on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis.","volume":"12","author":"Di Gregorio","year":"2017","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease: current management.","volume":"4","author":"Dignass","year":"2010","journal-title":"J. Crohns Colitis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1165\/rcmb.2009-0019OC","article-title":"Thrombospondin-1-deficient mice are not protected from bleomycin-induced pulmonary fibrosis.","volume":"44","author":"Ezzie","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0272-6386(01)80132-3","article-title":"Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro.","volume":"37","author":"Fan","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yexmp.2009.06.001","article-title":"IL-17 induces myocardial fibrosis and enhances RANKL\/OPG and MMP\/TIMP signaling in isoproterenol-induced heart failure.","volume":"87","author":"Feng","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1038\/mi.2008.41","article-title":"Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis.","author":"Fichtner-Feigl","year":"2008","journal-title":"Mucosal Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nm1332","article-title":"IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.","volume":"12","author":"Fichtner-Feigl","year":"2006","journal-title":"Nat. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"G677","DOI":"10.1152\/ajpgi.00104.2011","article-title":"Themes in fibrosis and gastrointestinal inflammation.","volume":"300","author":"Fiocchi","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"20202","DOI":"10.1074\/jbc.M110.102012","article-title":"Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis.","volume":"285","author":"Flier","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.cyto.2011.08.030","article-title":"Role of IL-13 in systemic sclerosis.","volume":"56","author":"Fuschiotti","year":"2011","journal-title":"Cytokine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/0016-5085(95)90630-4","article-title":"Corticosteroids increase procollagen gene expression, synthesis, and secretion by human intestinal smooth muscle cells.","volume":"109","author":"Graham","year":"1995","journal-title":"Gastroenterology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1359-6101(97)00010-5","article-title":"Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts.","volume":"8","author":"Grotendorst","year":"1997","journal-title":"Cytokine Growth Factor Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3109\/01902149509050842","article-title":"Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression.","volume":"21","author":"Gurujeyalakshmi","year":"1995","journal-title":"Exp. Lung Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2353\/ajpath.2007.060158","article-title":"Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.","volume":"170","author":"Hahm","year":"2007","journal-title":"Am. J. Pathol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/08977194.2011.595411","article-title":"Exploring anti-TGF-beta therapies in cancer and fibrosis.","volume":"29","author":"Hawinkels","year":"2011","journal-title":"Growth Factors"},{"key":"B34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","article-title":"Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells.","volume":"17","author":"Heller","year":"2002","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1053\/j.gastro.2017.06.013","article-title":"Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local rho kinase inhibitor.","volume":"153","author":"Holvoet","year":"2017","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1523-1755.2004.00779.x","article-title":"Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction.","volume":"66","author":"Inazaki","year":"2004","journal-title":"Kidney Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI20530","article-title":"Epithelial-mesenchymal transition and its implications for fibrosis.","volume":"112","author":"Kalluri","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/sj.onc.1209211","article-title":"Critical interactions between TGF-beta signaling\/ELF, and E-cadherin\/beta-catenin mediated tumor suppression.","volume":"25","author":"Katuri","year":"2006","journal-title":"Oncogene"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.ophtha.2007.03.050","article-title":"A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy.","volume":"114","author":"Khaw","year":"2007","journal-title":"Ophthalmology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.4049\/jimmunol.172.7.4068","article-title":"Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts.","volume":"172","author":"Kolodsick","year":"2004","journal-title":"J. Immunol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/ar2188","article-title":"Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions.","author":"Krieg","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015909","article-title":"PPAR-gamma ligands repress TGFbeta-induced myofibroblast differentiation by targeting the PI3K\/Akt pathway: implications for therapy of fibrosis.","volume":"6","author":"Kulkarni","year":"2011","journal-title":"PLoS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1073\/pnas.90.2.770","article-title":"Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.","volume":"90","author":"Kulkarni","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1046\/j.1365-2222.2002.01420.x","article-title":"Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma.","volume":"32","author":"Kumar","year":"2002","journal-title":"Clin. Exp. Allergy"},{"key":"B45","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma.","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat. Med."},{"key":"B46","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.4049\/jimmunol.162.4.2347","article-title":"Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways.","volume":"162","author":"Laan","year":"1999","journal-title":"J. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0002-9440(10)63289-0","article-title":"Targeted disruption of TGF-beta\/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.","volume":"165","author":"Lakos","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition.","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.crohns.2010.11.003","article-title":"In favour of early surgery in Crohn\u2019s disease: a hypothesis to be tested.","volume":"5","author":"Latella","year":"2011","journal-title":"J. Crohns Colitis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.3748\/wjg.v18.i29.3790","article-title":"Crucial steps in the natural history of inflammatory bowel disease.","volume":"18","author":"Latella","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.crohns.2014.03.008","article-title":"Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.","volume":"8","author":"Latella","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"B52","first-page":"1283","article-title":"Can we prevent, reduce or reverse intestinal fibrosis in IBD?","volume":"17","author":"Latella","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2362.2008.02076.x","article-title":"Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis.","volume":"39","author":"Latella","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"B54","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/S0955-0674(00)00143-5","article-title":"The functions of thrombospondin-1 and-2.","volume":"12","author":"Lawler","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1165\/ajrcmb.25.4.4522","article-title":"Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types.","volume":"25","author":"Lee","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"C436","DOI":"10.1152\/ajpcell.00423.2014","article-title":"Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.","volume":"310","author":"Lee","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.gastro.2003.07.004","article-title":"Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase.","volume":"125","author":"Leeb","year":"2003","journal-title":"Gastroenterology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0002-9440(10)63225-7","article-title":"Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1\/2 MAP kinase signaling pathway.","volume":"164","author":"Li","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00029330-200702010-00012","article-title":"Inhibition effect of small interfering RNA of connective tissue growth factor on the expression of vascular endothelial growth factor and connective tissue growth factor in cultured human peritoneal mesothelial cells.","volume":"120","author":"Liu","year":"2007","journal-title":"Chin. Med. J. (Engl.)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"G703","DOI":"10.1152\/ajpgi.00504.2010","article-title":"Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention.","volume":"300","author":"Luna","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1365-2796.2008.01950.x","article-title":"The interleukin-23\/Interleukin-17 axis in intestinal inflammation.","volume":"263","author":"Maloy","year":"2008","journal-title":"J. Intern. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3109\/10428194.2013.805329","article-title":"Anti-transforming growth factor-beta therapy in patients with myelofibrosis.","volume":"55","author":"Mascarenhas","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors.","volume":"19","author":"Massague","year":"2005","journal-title":"Genes Dev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1167\/iovs.02-0978","article-title":"Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.","volume":"44","author":"Mead","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"G684","DOI":"10.1152\/ajpgi.00474.2010","article-title":"Intestinal myofibroblasts: targets for stem cell therapy.","volume":"300","author":"Mifflin","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/mt.2011.290","article-title":"Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn\u2019s disease.","volume":"20","author":"Monteleone","year":"2012","journal-title":"Mol. Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa1407250","article-title":"Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn\u2019s disease.","volume":"372","author":"Monteleone","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/srep06424","article-title":"siRNAs targeted to Smad4 prevent renal fibrosis in vivo.","volume":"4","author":"Morishita","year":"2014","journal-title":"Sci. Rep."},{"key":"B69","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood.V66.5.1098.1098","article-title":"Localization of thrombospondin in clots formed in situ.","volume":"66","author":"Murphy-Ullrich","year":"1985","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.biocel.2008.02.016","article-title":"Hyper-responsiveness of IPF\/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2.","volume":"40","author":"Murray","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/31693","article-title":"Smad2 role in mesoderm formation, left-right patterning and craniofacial development.","volume":"393","author":"Nomura","year":"1998","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nature05894","article-title":"Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.","volume":"447","author":"Odegaard","year":"2007","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.4049\/jimmunol.1100504","article-title":"IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin.","volume":"186","author":"Oh","year":"2011","journal-title":"J. Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.ki.5002717","article-title":"Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.","volume":"73","author":"Petersen","year":"2008","journal-title":"Kidney Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","article-title":"Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.","volume":"179","author":"Piera-Velazquez","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"G653","DOI":"10.1152\/ajpgi.2000.279.4.G653","article-title":"Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models.","volume":"279","author":"Pucilowska","year":"2000","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000113790","article-title":"Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease.","volume":"75","author":"Punekar","year":"2008","journal-title":"Pathobiology"},{"key":"B78","first-page":"407","article-title":"Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis.","volume":"19","author":"Rastaldi","year":"2006","journal-title":"J. Nephrol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.","volume":"125","author":"Rice","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B80","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.crohns.2008.05.009","article-title":"Intestinal fibrosis in inflammatory bowel disease \u2013 Current knowledge and future perspectives.","volume":"2","author":"Rieder","year":"2008","journal-title":"J. Crohns Colitis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrgastro.2009.31","article-title":"Intestinal fibrosis in IBD\u2013a dynamic, multifactorial process.","volume":"6","author":"Rieder","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/ecco-jcc\/jjw055","article-title":"European crohn\u2019s and colitis organisation topical review on prediction, diagnosis and management of fibrostenosing crohn\u2019s disease.","volume":"10","author":"Rieder","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb03205.x","article-title":"Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta.","volume":"995","author":"Roberts","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/1753465808089363","article-title":"New perspectives in the treatment of idiopathic pulmonary fibrosis.","volume":"2","author":"Rogliani","year":"2008","journal-title":"Ther. Adv. Respir Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1051\/jbio:2006015","article-title":"[The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)].","volume":"200","author":"Rousseaux","year":"2006","journal-title":"J. Soc. Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1097\/MIB.0b013e318281f37a","article-title":"Cytokine-induced chromatin modifications of the type I collagen alpha 2 gene during intestinal endothelial-to-mesenchymal transition.","volume":"19","author":"Sadler","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1172\/JCI19270","article-title":"Targeted disruption of TGF-beta1\/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.","volume":"112","author":"Sato","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-015-0046-5","article-title":"Hallmarks of epithelial to mesenchymal transition are detectable in Crohn\u2019s disease associated intestinal fibrosis.","volume":"4","author":"Scharl","year":"2015","journal-title":"Clin. Transl. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ijrobp.2005.09.006","article-title":"Plasminogen activator inhibitor-I-related regulation of procollagen I (alpha1 and alpha2) by antitransforming growth factor-beta1 treatment during radiation-impaired wound healing.","volume":"64","author":"Schultze-Mosgau","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B91","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00384-006-0150-5","article-title":"Changes in surgical therapy for Crohn\u2019s disease over 33 years: a prospective longitudinal study.","volume":"22","author":"Siassi","year":"2007","journal-title":"Int. J. Colorectal. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1172\/JCI119590","article-title":"Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.","volume":"100","author":"Sime","year":"1997","journal-title":"J. Clin. Invest."},{"key":"B93","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00384-005-0739-0","article-title":"Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn\u2019s disease.","volume":"21","author":"Sorrentino","year":"2006","journal-title":"Int. J. Colorectal. Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.3748\/wjg.v18.i28.3635","article-title":"Cellular and molecular mechanisms of intestinal fibrosis.","volume":"18","author":"Speca","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2174\/138945010790309984","article-title":"Intestinal fibrosis in Crohn\u2019s disease: medical treatment or surgery?","volume":"11","author":"Spinelli","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"B96","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.matbio.2012.01.006","article-title":"Thrombospondin1 in tissue repair and fibrosis: TGF-beta-dependent and independent mechanisms.","volume":"31","author":"Sweetwyne","year":"2012","journal-title":"Matrix Biol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ki.2011.33","article-title":"A phase 1, single-dose study of fresolimumab, an anti-TGF-beta antibody, in treatment-resistant primary focal segmental glomerulosclerosis.","volume":"79","author":"Trachtman","year":"2011","journal-title":"Kidney Int."},{"key":"B98","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/17826","article-title":"Inhibition of transforming growth factor-beta\/SMAD signalling by the interferon-gamma\/STAT pathway.","volume":"397","author":"Ulloa","year":"1999","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","first-page":"vi","DOI":"10.1016\/j.rdc.2007.07.013","article-title":"Retroperitoneal fibrosis: evolving concepts.","volume":"33","author":"Vaglio","year":"2007","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"B100","doi-asserted-by":"publisher","first-page":"393","DOI":"10.20524\/aog.2017.0146","article-title":"Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface.","volume":"30","author":"Valatas","year":"2017","journal-title":"Ann. Gastroenterol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"G116","DOI":"10.1152\/ajpgi.00051.2005","article-title":"TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis.","volume":"289","author":"Vallance","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: special situations.","volume":"4","author":"Van Assche","year":"2010","journal-title":"J. Crohns Colitis"},{"key":"B103","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00441-011-1222-6","article-title":"Regulation of endothelial cell plasticity by TGF-beta.","volume":"347","author":"van Meeteren","year":"2012","journal-title":"Cell Tissue Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/BOR.0b013e32830e48e8","article-title":"Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis.","volume":"20","author":"Varga","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1056\/NEJMe1415053","article-title":"Oral SMAD7 antisense drug for Crohn\u2019s disease.","volume":"372","author":"Vermeire","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ki.2011.255","article-title":"Canonical Wnt\/beta-catenin signaling mediates transforming growth factor-beta1-driven podocyte injury and proteinuria.","volume":"80","author":"Wang","year":"2011","journal-title":"Kidney Int."},{"key":"B107","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3892\/ijmm.2011.594","article-title":"IL-17 expression is correlated with hepatitis Brelated liver diseases and fibrosis.","volume":"27","author":"Wang","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/ard.2004.029793","article-title":"Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature.","volume":"64","author":"Warnatz","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"L525","DOI":"10.1152\/ajplung.00163.2007","article-title":"TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease.","volume":"293","author":"Willis","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.","volume":"207","author":"Wilson","year":"2010","journal-title":"J. Exp. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.","volume":"117","author":"Wynn","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B112","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis.","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1681\/ASN.2013101137","article-title":"Curtailing endothelial TGF-beta signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.","volume":"26","author":"Xavier","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1165\/ajrcmb.23.2.4089","article-title":"A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat.","volume":"23","author":"Yehualaeshet","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3748\/wjg.v12.i8.1211","article-title":"Smad3 knock-out mice as a useful model to study intestinal fibrogenesis.","volume":"12","author":"Zanninelli","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat. Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.2741\/3204","article-title":"Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis.","volume":"13","author":"Zeisberg","year":"2008","journal-title":"Front. Biosci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00403-009-0959-1","article-title":"Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.","volume":"301","author":"Zhang","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"L585","DOI":"10.1152\/ajplung.00151.2001","article-title":"Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.","volume":"282","author":"Zhao","year":"2002","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00162\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:41:04Z","timestamp":1694634064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00162\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":119,"alternative-id":["10.3389\/fphar.2019.00162"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00162","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"article-number":"162"}}